Christos P. Argyropoulos earned his MD from the Medical School, University of Patras, Greece, in 1997. He was awarded his Ph.D. from the same institution for his work on the identification of the oncogene ets-2 as a transcriptional repressor in naïve T cells using a combination of statistical bioinformatics and wet-lab techniques. He completed his clinical Internal Medicine residency at the University of Cincinnati and his clinical nephrology and transplant fellowship at the University of Pittsburgh Medical Center in 2009. He joined the University of Pittsburgh as a postdoctoral research scholar in 2009 where he remained until late 2010. During this period, he worked on a number of patient-oriented research projects in Chronic Kidney Disease but also basic and translational research on kidney morphogenesis, the epithelial sodium channel and microRNAs. Between 2011 and 2014, he supported the ex-US Medical Affairs operations of Abbot Laboratories and AbbVie in Renal Care. He joined the Faculty of the University of New Mexico in May 2014 as an Assistant Professor of Nephrology. He has received a number of awards and distinctions, including the Renal Discoveries Grant from Baxter Healthcare (2008), the Frank Brans Teaching Award (Univeristy and Pittsburgh), the “try” program Abbott Laboratories (2012) and AbbVie’s Specialty Pharmaceutical Division Forum Expo (2014).